Clinical Research

Early pregnancy blood pressure patterns tied to hypertension risk years later
Researchers show certain blood pressure patterns during the first 20 weeks of pregnancy were more likely to develop into hypertension later in life.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
Society of Interventional Radiology Foundation seeks to bolster research funding for the specialty
During their annual meeting being held this week in Nashville, the society announced the launch of the SIR Foundation Endowment.
PET method offers new insight into inflammation of the brain
Researchers are hopeful that their technique could improve the diagnosis of conditions associated with neural inflammation.
Experts identify biomarker of severe asthma on MRI
Researchers are hopeful their findings could help improve the management of severe asthma.

New discovery paves the way for copper's entrance into MRI contrast agents

The new discovery contradicts the notion that copper is not suitable for use in contrast media.

The ReCor (left) and Medtronic Symplicity Spyral renal denervation systems.

FDA panel to review renal denervation system PMA submissions

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment.

FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease

The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

A figure from the study shows a chest radiograph with an area of consolidation involving right lower lung consistent with pneumonia, as well as right pleural effusion. The deep-learning model predicted risk of 30-day mortality of 9%. Right: Gradient- weighted class activation map shows that model prediction was influenced by separate area of image corresponding with heart and liver (yellow and light blue colors). Patient’s CURB-65 score was 4. Patient recovered from pneumonia and remained alive. AJR Image

Deep learning predicts pneumonia mortality on chest X-rays

AI was able to predict 30-day mortality risk predictions more accurately that the current risk assessment.

Video of Jon Lindner explaining the use of ultrasound and bubble contrast for therapy.

Cardiac ultrasound could lead to key advances in heart attack care, drug delivery

Jonathan Lindner, MD, offers an update on the use of echocardiography and bubble contrast agents in a therapy role to help revascularize STEMI patients and increase drug and gene delivery.

COVID causes increase risk of clotting. Example of a pulmonary embolism. CT pulmonary angiograms in a 77-year-old man with COVID-19 and a saddle embolus to pulmonary arteries (black arrow in A) extending into right and left pulmonary arteries (white arrows) in (A, B) axial and (C) coronal planes. Arrowheads show pulmonary changes associated with COVID-19 and possible lung infarction (black arrow in C). (D) Axial image at the level of the ventricles shows right-sided heart strain. RSNA. COVID PE

'Concerning' CT findings may lead to unnecessary hospitalization in PE patients

CT findings that have historically been deemed as concerning relative to PE might not hold as much weight when it comes to associated risks as previously thought, new analysis suggests.

New MRI technique offers detailed view of COVID's impact on the brain

The new technique mixes MRI signals at different gradient pulse strengths and timings, offering better visualization of differences in the way water molecules move through tissues.

AI primed for pulmonary nodule detection in adults, falls short in pediatric population

Artificial intelligence tools have proven to be beneficial in detecting pulmonary nodules on chest CTs of adults, but less is known about their utility in pediatric populations.

Clinical Research

Early pregnancy blood pressure patterns tied to hypertension risk years later

Key takeaways from ACC.25: Advances in cardiovascular science

Society of Interventional Radiology Foundation seeks to bolster research funding for the specialty

PET method offers new insight into inflammation of the brain

Experts identify biomarker of severe asthma on MRI